Ebola vaccine, Ervebo, receives FDA approval
by Press Release from Outbreak News Today on (#4WTZX)
The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. Cases of EVD are very rare in the U.S., and those that have occurred have been the result of infections acquired ["]
The post Ebola vaccine, Ervebo, receives FDA approval appeared first on Outbreak News Today.